| Target Price | $8.42 |
| Price | $0.40 |
| Potential |
2,030.38%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Ensysce Biosciences Inc 2027 .
The average Ensysce Biosciences Inc target price is $8.42.
This is
2,030.38%
register free of charge
$8.66
2,093.04%
register free of charge
$8.33
2,009.49%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend Ensysce Biosciences Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Ensysce Biosciences Inc stock has an average upside potential 2027 of
2,030.38%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 5.07 | 4.69 |
| 2.69% | 7.46% | |
| EBITDA Margin | -201.78% | -252.26% |
| 25.02% | ||
| Net Margin | -200.79% | -384.58% |
| 30.93% | 91.53% |
3 Analysts have issued a sales forecast Ensysce Biosciences Inc 2026 . The average Ensysce Biosciences Inc sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Ensysce Biosciences Inc EBITDA forecast 2026. The average Ensysce Biosciences Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 Ensysce Biosciences Inc Analysts have issued a net profit forecast 2026. The average Ensysce Biosciences Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -3.98 | -1.11 |
| 65.24% | 72.11% | |
| P/E | negative | |
| EV/Sales | 1.54 |
3 Analysts have issued a Ensysce Biosciences Inc forecast for earnings per share. The average Ensysce Biosciences Inc EPS is
This results in the following potential growth metrics and future valuations:
Ensysce Biosciences Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


